Dana E. Selley
Affiliations: | Pharmacology & Toxicology | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Pharmacology, Molecular BiologyGoogle:
"Dana Selley"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huang B, Ma H, Pagare PP, et al. (2024) Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder. Acs Pharmacology & Translational Science. 7: 4165-4182 |
| Pondelick AM, Moncayo LV, Donvito G, et al. (2024) Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P receptor-mediated G-protein activation in a mouse model of sciatic nerve injury. Neuropharmacology. 261: 110165 |
| Flammia R, Huang B, Pagare PP, et al. (2024) Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile. Bioorganic Chemistry. 148: 107489 |
| Diester CM, Balint H, Gillespie JC, et al. (2024) . The Journal of Pharmacology and Experimental Therapeutics |
| Li M, Pagare PP, Ma H, et al. (2023) Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory Depression. Journal of Medicinal Chemistry |
| Santos EJ, Nassehi N, Bow EW, et al. (2023) Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy. Pharmacology Research & Perspectives. 11: e01111 |
| Ma H, Pagare PP, Li M, et al. (2022) Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity. Journal of Medicinal Chemistry |
| Li M, Stevens DL, Arriaga M, et al. (2022) Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure-Activity Relationship Study on Nalfurafine Analogues. Acs Chemical Neuroscience |
| Chambers DR, Sulima A, Luo D, et al. (2022) A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists. Molecules (Basel, Switzerland). 27 |
| Pagare PP, Li M, Zheng Y, et al. (2022) Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists. Journal of Medicinal Chemistry |